retatrutide weight loss phase 2 trial vs Phase 3: Wild Results! New Phase 3 retatrutide data

(2023b)

The structure is the dual-subscription trap: cancel the medication and the membership keeps charging silently

After removing the supernatant, assay buffer added, and 2-NBDG fluorescence was measured using a microplate reader (excitation/emissio n = 485/535 nm)

Dempsey PC, Larsen RN, Sethi P et al (2016;dc152336) Benefits for type 2 diabetes of interrupting prolonged sitting with brief bouts of light walking or simple resistance activities

Most patients return to their pre-treatment weight within approximately 18 months of stopping

At events and corporate functions, the same questions kept popping up: How should we be thinking about GLP-1s